RICHARD CHMIELEWSKI: Open Payments
NPI 1396734794 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 15 payments from 9 companies in 2025. Trend: 2023 $632 · 2024 $761 · 2025 $455
Food & beverage: $410Education: $45
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $142 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $75 |
| Gilead Sciences, Inc. | 3 | $58 |
| Indivior Inc. | 2 | $49 |
| Lilly USA, LLC | 1 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Alkermes, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: FREESTYLE LIBRE 3, XIFAXAN, SUBLOCADE, CAPLYTA, VIVITROL, MAVYRET, ZORYVE.
Industry payments across NY — which companies pay providers there.
